[Featured Stock] Lunit, World-Class Technology Admired by US Biden and Bin Salman... Leading Global Cancer Conquest

Lunit's stock price is on the rise. This appears to be due to news that the company is participating in the large-scale cancer conquest project in the United States called ‘Cancer Moonshot’ and is also joining the ‘SEHA Virtual Hospital’ project, a core task of Saudi Arabia’s ‘Vision 2030’.

As of 10:21 AM on the 5th, Lunit is trading at 186,400 KRW, up 10.95% from the previous day.

Lunit announced that it will participate in the ‘SEHA Virtual Hospital’ project, a core task of Saudi Arabia’s ‘Vision 2030’.

The Vision 2030 project is a national strategic initiative actively promoted by Saudi Crown Prince Bin Salman to diversify the existing oil-centered industrial structure. The SEHA Virtual Hospital project is the top priority in the healthcare sector. It aims to introduce virtual hospitals utilizing digital technologies such as medical AI to healthcare institutions across Saudi Arabia and provide high-quality medical services. The Saudi government plans to invest a total of 66 billion USD (approximately 86 trillion KRW) to build medical infrastructure including virtual hospitals and expand private sector participation from 40% to 65%.

Earlier, Lunit was reported to have been listed as a founding member of Cancer Moonshot. According to the official website of CancerX, a public-private partnership promoting the US cancer conquest project ‘Cancer Moonshot,’ Lunit is included in the list of founding members.

Cancer Moonshot is a cancer conquest declaration announced by President Joe Biden during his vice presidency. It is an innovative cancer conquest project investing one billion dollars (approximately 1.15 trillion KRW), comparable to the challenge of the moon landing.

Seobum Seok, CEO of Lunit, said, "Following the visit of Saudi Crown Prince Bin Salman to Korea at the end of last year, the ‘New Middle East Boom’ has gained momentum, and domestic companies’ export expectations for the Saudi government’s Vision 2030 project are increasing." He added, "As the economic impact of this project is expected to be enormous and Lunit is actively participating in the SEHA Virtual Hospital project, we will continue to aggressively target the highly profitable Middle Eastern medical market."

Lunit is recognized for its world-class technology in AI-based cancer diagnosis and image analysis. Founded in 2013, Lunit is a first-generation medical AI company aiming to conquer cancer through AI customized solutions such as AI early cancer diagnosis (Lunit INSIGHT) and AI cancer treatment solutions (Lunit SCOPE).

This content was produced with the assistance of AI translation services.